Secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot phase II study

被引：0
|
作者：
Olivier Cussenot
Jean-Nicolas Cornu
Sarah J. Drouin
Pierre Mozer
Christophe Egrot
Christophe Vaessen
François Haab
Marc-Olivier Bitker
Morgan Rouprêt
机构：
[1] UPMC Univ Paris 06,Institut Universitaire de Cancérologie
[2] GRC-05,Academic Department of Urology
[3] ONCOTYPE-Uro,Academic Department of Urology
[4] Pitié-Salpétrière Hospital (Assistance Publique—Hôpitaux de Paris),undefined
[5] Tenon Hospital (Assistance Publique—Hôpitaux de Paris),undefined
来源：
World Journal of Urology | 2014年 / 32卷
关键词：
PSA; Androgen deprivation therapy; Prostate cancer; Chemoprevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：545 / 550
页数：5
相关论文
共 50 条
  • [31] Is there a relationship between testosterone levels at the end of short-term androgen deprivation therapy and outcomes in intermediate risk prostate cancer? Prospective data from a phase III trial.
    Nabid, Abdenour
    Garant, Marie-Pierre
    Vigneault, Eric
    Souhami, Luis
    Lemaire, Celine
    Brassard, Marc-Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [32] Short-Term Androgen Deprivation Therapy and High -Dose Radiotherapy in Intermediate- and High -Risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase III Trial
    Demogeot, N.
    Sargos, P.
    Sahki, N.
    Guerif, S.
    De Crevoisier, R.
    Calais, G.
    Hannoun-Levi, J. M.
    Bouche, G.
    Hennequin, C.
    Cretin, J.
    Belkacemi, Y.
    Khalifa, J.
    Azria, D.
    Bauer, N.
    Pommier, P.
    Pommier, P.
    Simon, J. M.
    Leger, C.
    Beckendorf, V.
    Dubray, B. M.
    Supiot, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S4 - S5
  • [33] A PHASE II, OPEN LABEL, RANDOMIZED CONTROLLED PILOT STUDY EVALUATING TRIMETHOPRIM IN PATIENTS COMMENCING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
    Shaun, Trecarten
    Jon, Gelfond
    Furkan, Dursun
    Michael, Liss
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [34] Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial
    Jones, Christopher U.
    Pugh, Stephanie L.
    Sandler, Howard M.
    Chetner, Michael P.
    Amin, Mahul B.
    Bruner, Deborah W.
    Zietman, Anthony L.
    Den, Robert B.
    Leibenhaut, Mark H.
    Longo, John M.
    Bahary, Jean-Paul
    Rosenthal, Seth A.
    Souhami, Luis
    Michalski, Jeff M.
    Hartford, Alan C.
    Amin, Pradip P.
    Roach, Mack
    Yee, Don
    Efstathiou, Jason A.
    Rodgers, Joseph P.
    Feng, Felix Y.
    Shipley, William U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (02): : 294 - 303
  • [35] Phase I/II study of sorafenib concurrent with androgen deprivation and radiotherapy in treatment of intermediate- and high-risk localized prostate cancer
    Talwar, S.
    Cohen, S. M.
    Romas, N. A.
    Ennis, R. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Phase III trial comparing long-term versus short-term androgen deprivation combined with high-dose radiotherapy for localized prostate cancer: GICOR protocol DART01/05.
    Zapatero, A.
    Guerrero, A.
    Maldonado, X.
    Alvarez, A.
    Gonzalez San Segundo, C.
    Cabeza, A.
    Macias, V.
    Casas, F.
    Pedro-Olive, A.
    Villa, S.
    Boladeras, A.
    Vazquez de La Torre, M. L.
    Martin de Vidales, C.
    Calvo, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] The short-term effects of resistance training on quality of life, cancer related fatigue, body composition, and physical function in men with advanced and metastatic prostate cancer receiving androgen deprivation therapy: a pilot study
    Murray, Leigh K.
    Bennett, Elizabeth Kamp
    PHYSICAL THERAPY REVIEWS, 2020, 25 (04) : 238 - 245
  • [38] Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer
    Bian, S. X.
    Kuban, D. A.
    Levy, L. B.
    Oh, J.
    Castle, K. O.
    Pugh, T. J.
    Choi, S.
    McGuire, S. E.
    Nguyen, Q. N.
    Frank, S. J.
    Nguyen, P. L.
    Lee, A. K.
    Hoffman, K. E.
    ANNALS OF ONCOLOGY, 2012, 23 (09) : 2346 - 2352
  • [39] Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with 68Ga-PSMA-11 PET/MRI in men with treatment-naive prostate cancer
    Ettala, Otto
    Malaspina, Simona
    Tuokkola, Terhi
    Luoto, Pauliina
    Loyttyniemi, Eliisa
    Bostrom, Peter J.
    Kemppainen, Jukka
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 665 - 673
  • [40] Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: Results of a phase II study
    Cookson, MS
    Sogani, PC
    Russo, P
    Sheinfeld, J
    Herr, H
    Dalbagni, G
    Reuter, VE
    Begg, CB
    Fair, WR
    BRITISH JOURNAL OF UROLOGY, 1997, 79 (03): : 432 - 438
12345